Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Moody

Showing results (51-60 of 200) with videos related to

Pageof 20
Sort By:
Journal of Virology|July 10, 2015
Rapid Development of gp120-Focused Neutralizing B Cell Responses during Acute Simian Immunodeficiency Virus Infection of African Green MonkeysJoshua D Amos, Jonathon E Himes, Lawrence Armand, et al.
Journal of Virological Methods|October 29, 2025
Validation of prototype virus inactivation from seven virus families of pandemic potential with a novel low-cost, field-deployable RNA extraction and storage methodMichelle L Rock, Jessica B Huskey, Sarah Hernandez, et al.
BMC Infectious Diseases|October 30, 2015
A systematic review of syphilis serological treatment outcomes in HIV-infected and HIV-uninfected persons: rethinking the significance of serological non-responsiveness and the serofast state after therapyArlene C Seña, Xiao-Hui Zhang, Trudy Li, et al.
NPJ Vaccines|May 16, 2020
Therapeutic vaccination with IDLV-SIV-Gag results in durable viremia control in chronically SHIV-infected macaquesMaria Blasi, Elizabeth C Wescott, Erich J Baker, et al.
Vaccine|September 17, 2018
Reactogenicity and immunogenicity of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant and nonpregnant womenKimberly B Fortner, Geeta K Swamy, Karen R Broder, et al.
Vaccine|September 20, 2025
Qualification of a reporter virus microneutralization assay for evaluation of influenza specific antibodies in human clinical trialsDimple Harit, Sheetal Sawant, Rachel L Spreng, et al.
Msphere|June 5, 2020
Induction of Neutralizing Responses against Autologous Virus in Maternal HIV Vaccine TrialsEliza D Hompe, Jesse F Mangold, Amit Kumar, et al.
Journal of Virology|July 14, 2017
Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1Kening Wang, Georgia D Tomaras, Sinthujan Jegaskanda, et al.
Frontiers in Immunology|May 6, 2014
Reconstructing a B-Cell Clonal Lineage. II. Mutation, Selection, and Affinity MaturationThomas B Kepler, Supriya Munshaw, Kevin Wiehe, et al.
Influenza and Other Respiratory Viruses|March 18, 2026
Strain Agnostic Influenza Virus Propagation in a Serum-Free, Suspension-Adapted MDCK Cell LineJessica B Huskey, Michelle L Rock, Pooja V Chaudhary, et al.
Pageof 20

Showing results (51-60 of 200) with videos related to

Sort By:
Pageof 20
Journal of Virology|July 10, 2015
Rapid Development of gp120-Focused Neutralizing B Cell Responses during Acute Simian Immunodeficiency Virus Infection of African Green MonkeysJoshua D Amos, Jonathon E Himes, Lawrence Armand, et al.
Journal of Virological Methods|October 29, 2025
Validation of prototype virus inactivation from seven virus families of pandemic potential with a novel low-cost, field-deployable RNA extraction and storage methodMichelle L Rock, Jessica B Huskey, Sarah Hernandez, et al.
BMC Infectious Diseases|October 30, 2015
A systematic review of syphilis serological treatment outcomes in HIV-infected and HIV-uninfected persons: rethinking the significance of serological non-responsiveness and the serofast state after therapyArlene C Seña, Xiao-Hui Zhang, Trudy Li, et al.
NPJ Vaccines|May 16, 2020
Therapeutic vaccination with IDLV-SIV-Gag results in durable viremia control in chronically SHIV-infected macaquesMaria Blasi, Elizabeth C Wescott, Erich J Baker, et al.
Vaccine|September 17, 2018
Reactogenicity and immunogenicity of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant and nonpregnant womenKimberly B Fortner, Geeta K Swamy, Karen R Broder, et al.
Vaccine|September 20, 2025
Qualification of a reporter virus microneutralization assay for evaluation of influenza specific antibodies in human clinical trialsDimple Harit, Sheetal Sawant, Rachel L Spreng, et al.
Msphere|June 5, 2020
Induction of Neutralizing Responses against Autologous Virus in Maternal HIV Vaccine TrialsEliza D Hompe, Jesse F Mangold, Amit Kumar, et al.
Journal of Virology|July 14, 2017
Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1Kening Wang, Georgia D Tomaras, Sinthujan Jegaskanda, et al.
Frontiers in Immunology|May 6, 2014
Reconstructing a B-Cell Clonal Lineage. II. Mutation, Selection, and Affinity MaturationThomas B Kepler, Supriya Munshaw, Kevin Wiehe, et al.
Influenza and Other Respiratory Viruses|March 18, 2026
Strain Agnostic Influenza Virus Propagation in a Serum-Free, Suspension-Adapted MDCK Cell LineJessica B Huskey, Michelle L Rock, Pooja V Chaudhary, et al.
Pageof 20